Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-08-27
Original SEC Filing: Click here

---

Webplus: SVA/20090827/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
SINOVAC RECEIVES REVISED APPROVALS FOR PANFLU Extension of Eligible Age Group Enables Sinovac to Cover Larger Part of Population Increased Panflu Dosage to 1mL per Vial Expands Filling and Packaging Capacity BEIJING, June 29 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that it has received a revised Drug

---

---

Webplus: SVA/20090827/6-K/1/000.htm SEC Original: sinovac6k062909.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-08-27CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085